Welcome to Monsanto Capital

Our aim: provide independent thinking


Since our inception, we have advised our clients in critical and highly complex deals offering unique and creative solutions.

Our aim: attract the most talented people


Since our inception, we have advised our clients in critical and highly complex deals offering unique and creative solutions.

Our aim: help clients achieve long term success


Since our inception, we have advised our clients in critical and highly complex deals offering unique and creative solutions.

Why Monsanto Capital

Our objective is to build long-term relationships with our clients offering them a value-added, differentiated and customized advisory service, based upon the following pillars:

Learn More

Senior Management Involvement

Senior Management always involved on every stage of the decision making process

Independent Advisory

Independent firm, exclusively dedicated to advisory services. Confidential advisory with full commitment to client objectives with no conflicts of interest

Experience

Highly experienced team with hands-on approach and with strong financial skills. Solid track record in terms of transactions and relationships

Long Term Focus

Our objective is to advise clients over the long term, not only on specific transactions, tailoring our services in the best interest of our clients

Recent Transactions

+

M&A BUY SIDE

M&A BUY SIDE

The Monsanto Team advised the shareholders of Joalpe, a manufacturer of plastic baskets focused on the large distribution in the acquisition of a minority shareholder.

M&A BUY SIDE

M&A BUY SIDE

Monsanto Team advised a Management team and the Fund Atena Equity Partners in the acquisition of LeYa, a Portuguese multinational publishing company.

M&A BUY SIDE

M&A BUY SIDE

Monsanto Capital, along with Oaklins’s team in Lithuania, advised the Lithuanian company InHouse Finance in the acquisition of Improxy – Tecnologias da Informação, a Portuguese company dedicated to developing professional software for the condominium and real estate market.

SELL SIDE

SELL SIDE

Monsanto advised the private shareholders of Laboratório S. José, a clinical analysis laboratory, on the sale of the company to SYNLAB.

Subscribe our Corporate Presentation